Ibuprofen Tablets USP — Class II drug recall D-1055-2022
Terminated recall by Mckesson Medical-Surgical Inc. Corporate Office, reported 2022-06-15, distributed nationwide. cGMP deviations: Temperature abuse
| Recall number | D-1055-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA, United States |
| Recall initiated | 2022-04-13 |
| Classified | 2022-06-09 |
| Reported by FDA | 2022-06-15 |
| Terminated | 2023-11-30 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp, temperature control |
| NDC | 00904-5853, 00904-5853-40, 00904-5853-60, 00904-5853-61, 00904-5854, 00904-5854-40, 00904-5854-60, 00904-5854-61, 00904-5855, 00904-5855-40, 00904-5855-60, 00904-5855-61 |
Product
Ibuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61
Reason for recall
cGMP deviations: Temperature abuse
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1055-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.